J. Michel

O. Dalesio, M. Buyse, N. Duez, 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

P. Dombernowsky, J. Bellmunt, T. Hatschek, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase Ii trial of fotemustine in advanced colorectal cancer.

F. Cavalli, H. Bleiberg, B. Gerard, 1990, European journal of cancer.

Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors.

J. Hildebrand, J. Brihaye, J. Michel, 1975, European journal of cancer.

Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors--a preliminary report.

J. Hildebrand, J. Brihaye, J. Michel, 1973, European Journal of Cancer.

Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).

M. Paesmans, J. Sculier, J. Klastersky, 1996, Lung cancer.

Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer

M. Paesmans, J. Sculier, J. Klastersky, 1994 .

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.

P. Rocmans, J. Sculier, J. Klastersky, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party.

J. Sculier, J. Klastersky, J. Lecomte, 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.

M. Paesmans, J. Sculier, F. Ries, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer

M. Paesmans, J. Sculier, J. Klastersky, 1990 .

HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide.

D. Larsimont, M. Piccart, J. Isola, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.

J. Bernheim, G. De Wasch, J. Michel, 1976, Cancer treatment reports.

Adjuvant immunotherapy by levamisole in resectable lung cancer: a control study.

O. Dalesio, P. Rocmans, P. van Houtte, 1980, European journal of cancer.

A phase II study evaluating CAVi (cyclophosphamide, adriamycin, vincristine) potentiated or not by amphotericin B entrapped into sonicated liposomes, as salvage therapy for small cell lung cancer

J. Sculier, J. Klastersky, R. Sergysels, 1990 .

Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study.

P. van Houtte, J. Sculier, J. Klastersky, 1988, Antibiotics and chemotherapy.

Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting.

V. Cocquyt, L. Stamatakis, S. Van Belle, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Hodgkins' disease with massive hepatic involvement and uninvolved spleen.

J. Heuson, J. Michel, Y. Kenis, 1973, European journal of cancer.

Phase II trial with chlorozotocin in advanced colorectal cancer.

M. Rozencweig, W. Feremans, N. Crespeigne, 1981, European journal of cancer & clinical oncology.

Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. "Leukemia and Hematosarcoma" Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.).

Rotterdam, M. Tubiana, G. Mathé, 1981, British journal of cancer.

Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC lung cancer working party (Belgium)

O. Dalesio, P. Rocmans, J. Sculier, 1985, Cancer.

a of Assessment of bone response to systemic therapy in an trial: preliminary with the use of cross-link

D. Lacombe, C. Rose, R. Coleman, 2021 .

Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer

R. Paridaens, E. Salamon, C. Focan, 2004, Cancer Chemotherapy and Pharmacology.